1. Goycochea-Valdivia WA, Ares Alvarez J, Conejo Fernan- dez AJ, et al. (2024): Position statement of the Spanish Society of Paediatric Infectious diseases on the diagnosis and treatment of Mycoplasma pneumoniae infection. An Pediatr (Engl Ed) 101: 46-57.
2.
Kenri T (2023): Genetic manipulation of Mycoplasma pneumoniae. Methods Mol Biol 2646: 347-357.
3.
Goeijenbier M, van der Bie S, Souverein D, et al. (2024): Post COVID-19 pandemic increased detection of Mycoplasma pneumoniae in adults admitted to the intensive care. J Clin Med 13: 3443.
4.
Peng Y, Chen Z, Li Y, et al. (2022): Combined therapy of Xiaoer Feire Kechuan oral liquid and azithromycin for mycoplasma Pneumoniae pneumonia in children: a systematic review and meta-analysis. Phytomedicine 96: 153899.
5.
Tsai TA, Tsai CK, Kuo KC, Yu HR (2021): Rational stepwise approach for Mycoplasma pneumoniae pneumonia in children. J Microbiol Immunol Infect 54: 557-565.
6.
Sandman Z, Iqbal OA. Azithromycin. StatPearls Publishing, Treasure Island (FL) 2025.
7.
Heidary M, Ebrahimi Samangani A, Kargari A, et al. (2022): Mechanism of action, resistance, synergism, and clinical implications of azithromycin. J Clin Lab Anal 36: e24427.
8.
8. Parnham MJ, Erakovic Haber V, Giamarellos-Bourboulis EJ, et al. (2014): Azithromycin: mechanisms of action and their relevance for clinical applications. Pharmacol Ther 143: 225-245.
9.
Chen M, Yang T, Meng X, Sun T (2015): Azithromycin attenuates cigarette smoke extract-induced oxidative stress injury in human alveolar epithelial cells. Mol Med Rep 11: 3414-3422.
10.
Tang F, Li R, Xue J et al. (2017): Azithromycin attenuates acute radiation-induced lung injury in mice. Oncol Lett 14: 5211-5220.
11.
Hassanein EHM, Sayed GA, Alzoghaibi AM, et al. (2022): Azithromycin mitigates cisplatin-induced lung oxidative stress, inflammation and necroptosis by upregulating SIRT1, PPARgamma, and Nrf2/HO-1 signaling. Pharmaceuticals (Basel) 16: 52.
12.
Birrell JM, Woolnough E, Spencer E (2019): Mycoplasma pneumoniae with para-infectious cerebral complications. Respir Med Case Rep 27: 100859.
13.
Dian D, Zhang W, Lu M, et al. (2023): Clinical efficacy of ulinastatin combined with azithromycin in the treatment of severe pneumonia in children and the effects on inflammatory cytokines and oxidative stress: a retrospective cohort study. Infect Drug Resist 16: 7165-7174.
14.
Chen Y, Dong S, Tian L, et al. (2022): Combination of azithromycin and methylprednisolone alleviates Mycoplasma pneumoniae induced pneumonia by regulating miR-499a-5p/STAT3 axis. Exp Ther Med 24: 578.
15.
Buendia I, Michalska P, Navarro E et al. (2016): Nrf2-ARE pathway: An emerging target against oxidative stress and neuroinflammation in neurodegenerative diseases. Pharmacol Ther 157: 84-104.
16.
Liang M, Meng Y, Wang X, et al. (2022): The effectiveness of wogonin on treating cough mice with Mycoplasma pneumoniae infection. Front Mol Biosci 9: 803842.
17.
17. Shi S, Zhang X, Zhou Y, et al. (2019): Immunosuppression reduces lung injury caused by Mycoplasma pneumoniae infection. Sci Rep 9: 7147.
18.
Liu X, Wang M, Kan Q, et al. (2022): Qingfei Tongluo formula mitigates Mycoplasma pneumoniae infection via the PERK signaling pathway. Dis Markers 2022: 9340353.
19.
Ma C, Gu C, Lian P, et al. (2023): Sulforaphane alleviates psoriasis by enhancing antioxidant defense through KEAP1-NRF2 Pathway activation and attenuating inflammatory signaling. Cell Death Dis 14: 768.
20.
Ding N, Lei A, Shi Z, et al. (2023): Total flavonoids from camellia oleifera alleviated Mycoplasma pneumoniae-induced lung injury via inhibition of the TLR2-mediated NF-kappaB and MAPK pathways. Molecules 28: 7077.
21.
Wei W, Wan H, Peng X, et al. (2018): Antiviral effects of Ma Huang Tang against H1N1 influenza virus infection in vitro and in an ICR pneumonia mouse model. Biomed Pharmacother 102: 1161-1175.
22.
Qian J, Xue M (2022): Pinocembrin relieves Mycoplasma pneumoniae infection induced pneumonia in mice through the inhibition of oxidative stress and inflammatory response. Appl Biochem Biotechnol 194: 6335-6348.
23.
Kang JY, Xu MM, Sun Y, et al. (2022): Melatonin attenuates LPS-induced pyroptosis in acute lung injury by inhibiting NLRP3-GSDMD pathway via activating Nrf2/HO-1 signaling axis. Int Immunopharmacol 109: 108782.
24.
24. Hu J, Ye Y, Chen X, et al. (2022): Insight into the pathogenic mechanism of Mycoplasma pneumoniae. Curr Microbiol 80: 14.
25.
Xue Y, Wang M, Han H (2023): Interaction between alveolar macrophages and epithelial cells during Mycoplasma pneumoniae infection. Front Cell Infect Microbiol 13: 1052020.
26.
Oliver ME, Hinks TSC (2021): Azithromycin in viral infections. Rev Med Virol 31: e2163.
27.
Jain S, Durugkar S, Saha P, et al. (2022): Effects of intranasal azithromycin on features of cigarette smoke-induced lung inflammation. Eur J Pharmacol 915: 174467.
28.
Ansari AW, Sharif-Askari FS, Jayakumar MN, et al. (2020): Azithromycin differentially alters TCR-activated helper T cell subset phenotype and effector function. Front Immunol 11: 556579.
29.
BioMed Research International (2023): Retracted: Kukoamine A improves Mycoplasma pneumoniae pneumonia by regulating miR-222-3p/superoxide dismutase 2. Biomed Res Int 2023: 9786745.
30.
Lana JV, Rios A, Takeyama R, et al. (2024): Nebulized glutathione as a key antioxidant for the treatment of oxidative stress in neurodegenerative conditions. Nutrients 16: 2476.
31.
Song Y, Fu W, Zhang Y, et al. (2023): Azithromycin ameliorated cigarette smoke-induced airway epithelial barrier dysfunction by activating Nrf2/GCL/GSH signaling pathway. Respir Res 24: 69.
